Six hundred and 34 drugs of various strengths produced by firms are suspected to be non-compliant with ceiling prices as notified by National Pharmaceutical Pricing Authority (NPPA). In its notification, the regulator said that it has issued the list after analysing the market data of various medicines in December last year.The list of cases of suspected non-compliance of notified ceiling prices issued by NPPA included medicines manufactured by leading pharmaceutical firms in India.
NPPA has been entrusted with the task of fixation and revision of prices of pharma products, enforcement of provisions of the Drugs Prices Control Order and monitoring of prices of controlled and decontrolled drugs.